학술논문
POS-045 Evaluating BCX9930, an Oral Factor D Inhibitor for Treatment of Complement-Mediated Kidney Disease: A Proof-of-Concept Study (RENEW)
Document Type
Abstract
Author
Source
In Kidney International Reports June 2022 7(6) Supplement:S457-S458
Subject
Language
ISSN
2468-0249